Subsequent entry biologics/biosimilars: a viewpoint from Canada. [electronic resource]
Producer: 20130317Description: 1289-92 p. digitalISSN:- 1434-9949
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Biological Therapy -- methods
- Biosimilar Pharmaceuticals -- therapeutic use
- Canada
- Chemistry, Pharmaceutical -- methods
- DNA -- metabolism
- Drug Costs
- Drug Industry -- trends
- Humans
- Infliximab
- Patient Safety
- Recombination, Genetic
- Rheumatology -- trends
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.